{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:14:37Z","timestamp":1772118877898,"version":"3.50.1"},"reference-count":89,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV 260 417"],"award-info":[{"award-number":["SVV 260 417"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Antidrug Policies c\/o Presidency, Council of Ministries (Italy)"},{"name":"\u201cL'Or\u00e9al Italia per le Donne e la Scienza","award":["2015\/2016"],"award-info":[{"award-number":["2015\/2016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Synapse"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1002\/syn.21976","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T17:07:25Z","timestamp":1492535245000},"page":"e21976","source":"Crossref","is-referenced-by-count":11,"title":["The current clinical knowledge on the treatment of gambling disorder: A summary"],"prefix":"10.1002","volume":"71","author":[{"given":"Karel","family":"Hloch","sequence":"first","affiliation":[{"name":"Department of Social and Clinical Pharmacy; Faculty of Pharmacy, Charles University; Heyrovskeho 1203 Hradec Kralove 500 05 Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0159emysl","family":"Mlad\u011bnka","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology; Faculty of Pharmacy, Charles University; Heyrovskeho 1203 Hradec Kralove 500 05 Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5253-7967","authenticated-orcid":false,"given":"Martin","family":"Dosed\u011bl","sequence":"additional","affiliation":[{"name":"Department of Social and Clinical Pharmacy; Faculty of Pharmacy, Charles University; Heyrovskeho 1203 Hradec Kralove 500 05 Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Adriani","sequence":"additional","affiliation":[{"name":"Centre for Behavioural Sciences and Mental Health; Istituto Superiore di Sanit\u00e0; Viale Regina Elena 299 Rome I-00161 Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Zoratto","sequence":"additional","affiliation":[{"name":"Unit of Cognitive Primatology and Primate Centre; Institute of Cognitive Sciences and Technologies of the National Research Council of Italy; Via Ulisse Aldrovandi 16\/B Rome I-00197 Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"10.1002\/syn.21976-BIB0001|syn21976-cit-0002","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","edition":"5"},{"issue":"2","key":"10.1002\/syn.21976-BIB0002|syn21976-cit-0003","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0033291796003789","article-title":"Altered dopamine function in pathological gambling","volume":"27","author":"Bergh","year":"1997","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/syn.21976-BIB0003|syn21976-cit-0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1002\/syn.21976-BIB0004|syn21976-cit-0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/15622975.2011.560964","article-title":"A double-blind, placebo-controlled trial of topiramate for pathological gambling","volume":"14","author":"Berlin","year":"2013","journal-title":"The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"issue":"1","key":"10.1002\/syn.21976-BIB0005|syn21976-cit-0006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of bupropion in the treatment of pathologic gambling","volume":"24","author":"Black","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/syn.21976-BIB0006|syn21976-cit-0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.jcp.0000264985.25109.25","article-title":"Bupropion in the treatment of pathological gambling: A randomized, double-blind, placebo-controlled, flexible-dose study","volume":"27","author":"Black","year":"2007a","journal-title":"Journal of Clin Psychopharmacology"},{"issue":"4","key":"10.1002\/syn.21976-BIB0007|syn21976-cit-0008","first-page":"250","article-title":"An open-label trial of acamprosate in the treatment of pathological gambling","volume":"23","author":"Black","year":"2011","journal-title":"Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists"},{"issue":"5","key":"10.1002\/syn.21976-BIB0008|syn21976-cit-0009","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2008.02.013","article-title":"Extended release carbamazepine in the treatment of pathological gambling: An open-label study","volume":"32","author":"Black","year":"2008","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"4","key":"10.1002\/syn.21976-BIB0009|syn21976-cit-0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/wnf.0b013e31803d357f","article-title":"An open-label trial of escitalopram in the treatment of pathological gambling","volume":"30","author":"Black","year":"2007b","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/syn.21976-BIB0010|syn21976-cit-0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling","volume":"14","author":"Blanco","year":"2002","journal-title":"Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists"},{"issue":"5","key":"10.1002\/syn.21976-BIB0011|syn21976-cit-0012","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1360-0443.2002.00015.x","article-title":"A pathways model of problem and pathological gambling","volume":"97","author":"Blaszczynski","year":"2002","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/syn.21976-BIB0012|syn21976-cit-0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01019930","article-title":"Plasma endorphin levels in pathological gambling","volume":"2","author":"Blaszczynski","year":"1986","journal-title":"Journal of Gambling Behavior"},{"issue":"1","key":"10.1002\/syn.21976-BIB0013|syn21976-cit-0014","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/2211557911201010067","article-title":"Pathological gambling: Neuropsychopharmacology and treatment","volume":"1","author":"Bullock","year":"2012","journal-title":"Current Psychopharmacology"},{"issue":"4","key":"10.1002\/syn.21976-BIB0014|syn21976-cit-0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0006-3223(01)01227-6","article-title":"Frontal lobe dysfunction in pathological gambling patients","volume":"51","author":"Cavedini","year":"2002","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1002\/syn.21976-BIB0015|syn21976-cit-0016","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biopsych.2013.08.026","article-title":"A selective role for dopamine D(4) receptors in modulating reward expectancy in a rodent slot machine task","volume":"75","author":"Cocker","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/syn.21976-BIB0016|syn21976-cit-0017","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008571-199606000-00004","article-title":"A study of the dopamine D2 receptor gene in pathological gambling","volume":"6","author":"Comings","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1002\/syn.21976-BIB0017|syn21976-cit-0018","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1196\/annals.1300.021","article-title":"Glutamatergic agents for cocaine dependence","volume":"1003","author":"Dackis","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1002\/syn.21976-BIB0018|syn21976-cit-0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacol"},{"key":"10.1002\/syn.21976-BIB0019|syn21976-cit-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00033","article-title":"Acamprosate and baclofen were not effective in the treatment of pathological gambling: Preliminary blind rater comparison study","volume":"2","author":"Dannon","year":"2011","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"10.1002\/syn.21976-BIB0020|syn21976-cit-0021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topiramate versus fluvoxamine in the treatment of pathological gambling: A randomized, blind-rater comparison study","volume":"28","author":"Dannon","year":"2005a","journal-title":"Clinical Neuropharmacology"},{"issue":"6","key":"10.1002\/syn.21976-BIB0021|syn21976-cit-0022","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: A preliminary blind-rater study","volume":"25","author":"Dannon","year":"2005b","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/syn.21976-BIB0022|syn21976-cit-0023","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2165\/00023210-199707060-00004","article-title":"Selective serotonin reuptake inhibitors","volume":"7","author":"Jonghe","year":"1997","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1002\/syn.21976-BIB0023|syn21976-cit-0024","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/npp.2008.175","article-title":"Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers","volume":"34","author":"Ruiter","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/syn.21976-BIB0024|syn21976-cit-0025","first-page":"235","article-title":"The neurobiology of pleasure, reward processes, addiction and their health implications","volume":"25","author":"Esch","year":"2004","journal-title":"Neuro Endocrinology Letters"},{"issue":"4","key":"10.1002\/syn.21976-BIB0025|syn21976-cit-0026","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1530-0277.2007.00339.x","article-title":"Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: Results from the VA cooperative study","volume":"31","author":"Gelernter","year":"2007","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"2","key":"10.1002\/syn.21976-BIB0026|syn21976-cit-0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/ijamh-2015-5005","article-title":"The role of serotonin in impulsive aggression, suicide, and homicide in adolescents and adults: A literature review","volume":"27","author":"Glick","year":"2015","journal-title":"International Journal of Adolescent Medicine and Health"},{"issue":"4","key":"10.1002\/syn.21976-BIB0027|syn21976-cit-0028","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-010-1994-5","article-title":"Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: A pilot study","volume":"212","author":"Grant","year":"2010a","journal-title":"Psychopharmacol (Berl)"},{"issue":"5","key":"10.1002\/syn.21976-BIB0028|syn21976-cit-0029","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","article-title":"A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","volume":"69","author":"Grant","year":"2008a","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1002\/syn.21976-BIB0029|syn21976-cit-0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1235-3","article-title":"Predicting response to opiate antagonists and placebo in the treatment of pathological gambling","author":"Grant","year":"2008b","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1002\/syn.21976-BIB0030|syn21976-cit-0031","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/syn.21976-BIB0031|syn21976-cit-0032","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004850-200307000-00007","article-title":"Paroxetine treatment of pathological gambling: A multi-centre randomized controlled trial","volume":"18","author":"Grant","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/syn.21976-BIB0032|syn21976-cit-0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.13m08411","article-title":"A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers","volume":"75","author":"Grant","year":"2014","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/syn.21976-BIB0033|syn21976-cit-0034","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","article-title":"Nalmefene in the treatment of pathological gambling: Multicentre, double-blind, placebo-controlled study","volume":"197","author":"Grant","year":"2010b","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"issue":"4","key":"10.1002\/syn.21976-BIB0034|syn21976-cit-0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","article-title":"Escitalopram treatment of pathological gambling with co-occurring anxiety: An open-label pilot study with double-blind discontinuation","volume":"21","author":"Grant","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/syn.21976-BIB0035|syn21976-cit-0036","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/syn.21976-BIB0036|syn21976-cit-0037","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/syn.21976-BIB0037|syn21976-cit-0038","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1002\/syn.21976-BIB0038|syn21976-cit-0039","volume-title":"Endogenous opioids and addiction (The pharmacology of opioids)","author":"Herz","year":"1995"},{"key":"10.1002\/syn.21976-BIB0039|syn21976-cit-0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2015.05.013","article-title":"Alterations in DNA-methylation of the dopamine-receptor 2 gene are associated with abstinence and health care utilization in individuals with a lifetime history of pathologic gambling","volume":"63","author":"Hillemacher","year":"2015","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"3","key":"10.1002\/syn.21976-BIB0040|syn21976-cit-0041","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0193-953X(05)70185-4","article-title":"Pathological gambling","volume":"23","author":"Hollander","year":"2000a","journal-title":"The Psychiatric Clinics of North America"},{"issue":"9","key":"10.1002\/syn.21976-BIB0041|syn21976-cit-0042","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathologic gambling","volume":"47","author":"Hollander","year":"2000b","journal-title":"Biological Psychiatry"},{"issue":"12","key":"10.1002\/syn.21976-BIB0042|syn21976-cit-0043","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1176\/ajp.155.12.1781","article-title":"Short-term single-blind fluvoxamine treatment of pathological gambling","volume":"155","author":"Hollander","year":"1998","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/syn.21976-BIB0043|syn21976-cit-0044","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1176\/ajp.149.5.710b","article-title":"Treatment of pathological gambling with clomipramine","volume":"149","author":"Hollander","year":"1992","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/syn.21976-BIB0044|syn21976-cit-0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/syn.21976-BIB0045|syn21976-cit-0046","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder","volume":"16","author":"Kim","year":"2001","journal-title":"International Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/syn.21976-BIB0046|syn21976-cit-0047","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/syn.21976-BIB0047|syn21976-cit-0048","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling","volume":"63","author":"Kim","year":"2002","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/syn.21976-BIB0048|syn21976-cit-0049","first-page":"628","article-title":"Brain activity during cocaine craving and gambling urges: An fMRI study","volume":"41","author":"Kober","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1002\/syn.21976-BIB0049|syn21976-cit-0050","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.neuropharm.2011.11.002","article-title":"Compromised decision-making and increased gambling proneness following dietary serotonin depletion in rats","volume":"62","author":"Koot","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1002\/syn.21976-BIB0050|syn21976-cit-0051","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000435876","article-title":"A randomised, double-blind, placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling","volume":"22","author":"Kovanen","year":"2016","journal-title":"European Addiction Research"},{"issue":"5","key":"10.1002\/syn.21976-BIB0051|syn21976-cit-0052","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pharep.2014.05.003","article-title":"The latest achievements in the pharmacotherapy of gambling disorder","volume":"66","author":"Labuzek","year":"2014","journal-title":"Pharmacological Reports"},{"issue":"1","key":"10.1002\/syn.21976-BIB0052|syn21976-cit-0053","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"The American Journal on Addictions"},{"issue":"6","key":"10.1002\/syn.21976-BIB0053|syn21976-cit-0054","first-page":"456","article-title":"Ministry of health clinical practice guidelines: Management of gambling disorders","volume":"52","author":"Lee","year":"2011","journal-title":"Singapore Med J"},{"issue":"2","key":"10.1002\/syn.21976-BIB0054|syn21976-cit-0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2550-7","article-title":"Similarities and differences between pathological gambling and substance use disorders: A focus on impulsivity and compulsivity","volume":"219","author":"Leeman","year":"2012","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/syn.21976-BIB0055|syn21976-cit-0056","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1360-0443.2010.03126.x","article-title":"Dopamine release in ventral striatum during Iowa gambling task performance is associated with increased excitement levels in pathological gambling","volume":"106","author":"Linnet","year":"2011","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/syn.21976-BIB0056|syn21976-cit-0057","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0447.2010.01591.x","article-title":"Dopamine release in ventral striatum of pathological gamblers losing money","volume":"122","author":"Linnet","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/syn.21976-BIB0057|syn21976-cit-0058","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2009.02671.x","article-title":"Genetic aspects of pathological gambling: A complex disorder with shared genetic vulnerabilities","volume":"104","author":"Lobo","year":"2009","journal-title":"Addiction"},{"issue":"7","key":"10.1002\/syn.21976-BIB0058|syn21976-cit-0059","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1440-1819.2011.02264.x","article-title":"Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials","volume":"65","author":"Maneeton","year":"2011","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"2","key":"10.1002\/syn.21976-BIB0059|syn21976-cit-0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40263-014-0142-x","article-title":"Potential role of N-acetylcysteine in the management of substance use disorders","volume":"28","author":"McClure","year":"2014","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1002\/syn.21976-BIB0060|syn21976-cit-0061","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.psyneuen.2004.03.005","article-title":"Neuroendocrine response to casino gambling in problem gamblers","volume":"29","author":"Meyer","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1002\/syn.21976-BIB0061|syn21976-cit-0062","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hup.470060503","article-title":"Serotonin and gambling dependence","volume":"6","author":"Moreno","year":"1991","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"Part B","key":"10.1002\/syn.21976-BIB0062|syn21976-cit-0063","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuropharm.2013.04.004","article-title":"Epigenetic mechanisms of drug addiction","volume":"76","author":"Nestler","year":"2014","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1002\/syn.21976-BIB0063|syn21976-cit-0064","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jpsychires.2005.06.003","article-title":"CSF monoamine patterns in pathological gamblers and healthy controls","volume":"40","author":"Nordin","year":"2006","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1002\/syn.21976-BIB0064|syn21976-cit-0065","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10899-014-9503-0","article-title":"Dopaminergic medication in Parkinson's disease and problem gambling","volume":"31","author":"Olley","year":"2015","journal-title":"Journal of Gambling Studies"},{"issue":"8","key":"10.1002\/syn.21976-BIB0065|syn21976-cit-0066","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1002\/syn.21976-BIB0066|syn21976-cit-0067","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v63n1114","article-title":"Nefazodone treatment of pathological gambling: A prospective open-label controlled trial","volume":"63","author":"Pallanti","year":"2002a","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/syn.21976-BIB0067|syn21976-cit-0068","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/0269881109106907","article-title":"Serotonin function in pathological gambling: Blunted growth hormone response to sumatriptan","volume":"24","author":"Pallanti","year":"2010","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"7","key":"10.1002\/syn.21976-BIB0068|syn21976-cit-0069","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","article-title":"Lithium and valproate treatment of pathological gambling: A randomized single-blind study","volume":"63","author":"Pallanti","year":"2002b","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"42","key":"10.1002\/syn.21976-BIB0069|syn21976-cit-0070","doi-asserted-by":"crossref","first-page":"10509","DOI":"10.1523\/JNEUROSCI.2807-08.2008","article-title":"Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses","volume":"28","author":"Petrovic","year":"2008","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"1","key":"10.1002\/syn.21976-BIB0070|syn21976-cit-0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-9338(13)77453-4","article-title":"Glutamatergic strategies in the treatment of pathological gambling: A pilot study","volume":"28","author":"Pettorruso","year":"2013","journal-title":"European Psychiatry"},{"key":"10.1002\/syn.21976-BIB0071|syn21976-cit-0072","doi-asserted-by":"crossref","first-page":"109786","DOI":"10.1155\/2014\/109786","article-title":"Targeting the glutamatergic system to treat pathological gambling: Current evidence and future perspectives","volume":"2014","author":"Pettorruso","year":"2014","journal-title":"Biomed Research International"},{"key":"10.1002\/syn.21976-BIB0072|syn21976-cit-0073","first-page":"1725","volume-title":"Neuropsychopharmacol the 5th generation of progress","author":"Potenza","year":"2002"},{"issue":"2","key":"10.1002\/syn.21976-BIB0073|syn21976-cit-0074","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","article-title":"Pathological gambling is linked to reduced activation of the mesolimbic reward system","volume":"8","author":"Reuter","year":"2005","journal-title":"Nature Neuroscience"},{"issue":"11","key":"10.1002\/syn.21976-BIB0074|syn21976-cit-0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/11316580-000000000-00000","article-title":"Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: A systematic review and meta-analysis","volume":"32","author":"Rief","year":"2009","journal-title":"Drug Safety"},{"issue":"4","key":"10.1002\/syn.21976-BIB0075|syn21976-cit-0076","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1988.01800280085011","article-title":"Pathological gambling. A psychobiological study","volume":"45","author":"Roy","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/syn.21976-BIB0076|syn21976-cit-0077","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4088\/JCP.v66n0104","article-title":"Sertraline treatment of pathological gambling: A pilot study","volume":"66","author":"Saiz-Ruiz","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1002\/syn.21976-BIB0077|syn21976-cit-0078","first-page":"161","article-title":"Patologick\u00e9 hr\u00e1\u010dstv\u00ed","volume":"4","author":"\u0160er\u00fd","year":"2001","journal-title":"Psychiatrie Pro Praxi"},{"key":"10.1002\/syn.21976-BIB0078|syn21976-cit-0079","volume-title":"The anxiety disease","author":"Sheehan","year":"1986"},{"issue":"2","key":"10.1002\/syn.21976-BIB0079|syn21976-cit-0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2114\/jpa.18.37","article-title":"Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate","volume":"18","author":"Shinohara","year":"1999","journal-title":"Applied Human Science: Journal of Physiological Anthropology"},{"issue":"6","key":"10.1002\/syn.21976-BIB0080|syn21976-cit-0081","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1002\/syn.21976-BIB0081|syn21976-cit-0082","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Annals of Neurology"},{"issue":"11\/12","key":"10.1002\/syn.21976-BIB0082|syn21976-cit-0083","doi-asserted-by":"crossref","first-page":"664","DOI":"10.5694\/mja11.11088","article-title":"Australian guideline for treatment of problem gambling: An abridged outline","volume":"195","author":"Thomas","year":"2011","journal-title":"Medical Journal of Australia"},{"issue":"1-3","key":"10.1002\/syn.21976-BIB0083|syn21976-cit-0084","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(00)00544-6","article-title":"Endogenous opioids and reward","volume":"405","author":"Ree","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1002\/syn.21976-BIB0084|syn21976-cit-0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"2","key":"10.1002\/syn.21976-BIB0085|syn21976-cit-0086","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01539176","article-title":"The prevalence of problem and pathological gambling: A critical analysis","volume":"12","author":"Walker","year":"1996","journal-title":"Journal of Gambling Studies"},{"issue":"1","key":"10.1002\/syn.21976-BIB0086|syn21976-cit-0087","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.npp.1300333","article-title":"Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers","volume":"29","author":"Zack","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/syn.21976-BIB0087|syn21976-cit-0088","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/0269881108091072","article-title":"Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity","volume":"23","author":"Zack","year":"2009","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1002\/syn.21976-BIB0088|syn21976-cit-0089","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4088\/JCP.v63n0109","article-title":"An open-label study of citalopram in the treatment of pathological gambling","volume":"63","author":"Zimmerman","year":"2002","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1002\/syn.21976-BIB0089|syn21976-cit-0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2016.10.041","article-title":"Down-regulation of serotonin and dopamine transporter genes in individual rats expressing a gambling-prone profile: A possible role for epigenetic mechanisms","volume":"340","author":"Zoratto","year":"2017","journal-title":"Neuroscience"}],"container-title":["Synapse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsyn.21976","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/syn.21976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T01:09:01Z","timestamp":1692752941000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/syn.21976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/syn.21976","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727514904.793544310","asserted-by":"object"}]},"ISSN":["0887-4476"],"issn-type":[{"value":"0887-4476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}